Actively Recruiting
3D DL Ozteo in the Detection of Osseous Changes in Patients With Inflammatory Arthritis
Led by Mayo Clinic · Updated on 2025-12-17
25
Participants Needed
1
Research Sites
103 weeks
Total Duration
On this page
Sponsors
M
Mayo Clinic
Lead Sponsor
G
GE Healthcare
Collaborating Sponsor
AI-Summary
What this Trial Is About
This project intends to explore and validate the utility of new MRI pulse sequence, 3D DL oZTEo, in the detection of osseous erosions of the hand in patients with inflammatory arthritis. The detection of osseous structural changes, such as erosive disease, is routinely assessed in patients with rheumatic conditions such as rheumatoid arthritis, as it alters clinical management, and in some cases assists in diagnosis. Currently, this is most often assessed with radiography and conventional MRI.
CONDITIONS
Official Title
3D DL Ozteo in the Detection of Osseous Changes in Patients With Inflammatory Arthritis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult patients 18 years of age or older
- Hand radiographs performed within the past 3-6 months with imaging results available for analysis
- Hand radiographs confirm the presence of bony erosions
- Scheduled for a hand MRI as part of their routine clinical care at Mayo Clinic Rochester
You will not qualify if you...
- Less than 18 years of age
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Mayo Clinic in Rochester
Rochester, Minnesota, United States, 55905
Actively Recruiting
Research Team
N
Naveen S Murthy, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here